Envestnet Asset Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-134,645
| Closed | -$13.7M | – | 4749 |
|
|
2025
Q4 | $13.7M | Sell |
134,645
-124,660
| -48% | -$10M | ﹤0.01% | 1495 |
|
|
2025
Q3 | $14.2M | Buy |
259,305
+10,770
| +4% | +$538K | ﹤0.01% | 1526 |
|
|
2025
Q2 | $13.2M | Buy |
248,535
+2,182
| +0.9% | +$111K | ﹤0.01% | 1543 |
|
|
2025
Q1 | $10.7M | Sell |
246,353
-8,891
| -3% | -$450K | ﹤0.01% | 1623 |
|
|
2024
Q4 | $14.3M | Sell |
255,244
-44,424
| -15% | -$2.76M | ﹤0.01% | 1402 |
|
|
2024
Q3 | $20.4M | Sell |
299,668
-27,242
| -8% | -$1.54M | 0.01% | 1175 |
|
|
2024
Q2 | $13.8M | Sell |
326,910
-10,826
| -3% | -$596K | ﹤0.01% | 1353 |
|
|
2024
Q1 | $23.3M | Sell |
337,736
-63,594
| -16% | -$4.02M | 0.01% | 1020 |
|
|
2023
Q4 | $29.7M | Buy |
401,330
+34,540
| +9% | +$2.26M | 0.01% | 834 |
|
|
2023
Q3 | $25M | Buy |
366,790
+42,896
| +13% | +$3.64M | 0.01% | 855 |
|
|
2023
Q2 | $30.4M | Sell |
323,894
-4,360
| -1% | -$340K | 0.01% | 715 |
|
|
2023
Q1 | $22.3M | Sell |
328,254
-25,570
| -7% | -$1.64M | 0.01% | 827 |
|
|
2022
Q4 | $17.5M | Buy |
353,824
+42,712
| +14% | +$1.75M | 0.01% | 920 |
|
|
2022
Q3 | $10.1M | Sell |
311,112
-3,063
| -1% | -$126K | 0.01% | 1125 |
|
|
2022
Q2 | $12.4M | Sell |
314,175
-8,421
| -3% | -$450K | 0.01% | 1036 |
|
|
2022
Q1 | $22.6M | Sell |
322,596
-20,851
| -6% | -$1.52M | 0.01% | 795 |
|
|
2021
Q4 | $26.7M | Buy |
343,447
+44,414
| +15% | +$3.92M | 0.01% | 723 |
|
|
2021
Q3 | $28.5M | Buy |
299,033
+45,744
| +18% | +$4.83M | 0.02% | 651 |
|
|
2021
Q2 | $31.5M | Buy |
253,289
+33,301
| +15% | +$3.97M | 0.02% | 615 |
|
|
2021
Q1 | $29M | Buy |
219,988
+57,204
| +35% | +$7.83M | 0.02% | 586 |
|
|
2020
Q4 | $21.6M | Buy |
162,784
+32,448
| +25% | +$3.92M | 0.02% | 594 |
|
|
2020
Q3 | $13.3M | Buy |
130,336
+94,492
| +264% | +$8.16M | 0.01% | 712 |
|
|
2020
Q2 | $3.12M | Sell |
35,844
-2,597
| -7% | -$207K | ﹤0.01% | 1355 |
|
|
2020
Q1 | $2.23M | Sell |
38,441
-5,378
| -12% | -$437K | ﹤0.01% | 1364 |
|
|
2019
Q4 | $4.05M | Buy |
43,819
+14,152
| +48% | +$1.24M | ﹤0.01% | 1246 |
|
|
2019
Q3 | $2.68M | Buy |
29,667
+5,657
| +24% | +$645K | ﹤0.01% | 1388 |
|
|
2019
Q2 | $2.83M | Buy |
24,010
+2,361
| +11% | +$238K | ﹤0.01% | 1354 |
|
|
2019
Q1 | $1.88M | Sell |
21,649
-1,464
| -6% | -$125K | ﹤0.01% | 1519 |
|
|
2018
Q4 | $1.46M | Buy |
23,113
+12,332
| +114% | +$846K | ﹤0.01% | 1511 |
|
|
2018
Q3 | $851K | Buy |
10,781
+8,162
| +312% | +$532K | ﹤0.01% | 786 |
|
|
2018
Q2 | $156K | Buy |
2,619
+18
| +0.7% | +$969 | ﹤0.01% | 1789 |
|
|
2018
Q1 | $106K | Sell |
2,601
-124
| -5% | -$6.05K | ﹤0.01% | 1884 |
|
|
2017
Q4 | $143K | Buy |
2,725
+173
| +7% | +$9.24K | ﹤0.01% | 1979 |
|
|
2017
Q3 | $121K | Sell |
2,552
-46
| -2% | -$1.85K | ﹤0.01% | 2017 |
|
|
2017
Q2 | $92K | Buy |
2,598
+422
| +19% | +$13K | ﹤0.01% | 2168 |
|
|
2017
Q1 | $52K | Buy |
2,176
+343
| +19% | +$6.8K | ﹤0.01% | 2398 |
|
|
2016
Q4 | $25K | Sell |
1,833
-411
| -18% | -$6.63K | ﹤0.01% | 2613 |
|
|
2016
Q3 | $42K | Buy |
2,244
+1,064
| +90% | +$18.7K | ﹤0.01% | 2653 |
|
|
2016
Q2 | $14K | Sell |
1,180
-504
| -30% | -$3.8K | ﹤0.01% | 3008 |
|
|
2016
Q1 | $11K | Sell |
1,684
-4,361
| -72% | -$27.9K | ﹤0.01% | 3032 |
|
|
2015
Q4 | $56K | Buy |
6,045
+2,308
| +62% | +$21.5K | ﹤0.01% | 2628 |
|
|
2015
Q3 | $67K | Buy |
+3,737
| New | +$85.8K | ﹤0.01% | 2518 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Envestnet Asset Management's EXAS Position: Q1 2026 in Review
Envestnet Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 134,645 shares — an estimated $13.7M sold.
Envestnet Asset Management first reported a position in EXAS in Q3 2015 and held it in 42 quarters. The position peaked at $31.5M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Envestnet Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Envestnet Asset Management sold 134,645 Exact Sciences shares in Q1 2026, an estimated $13.7M.
- Envestnet Asset Management first reported a position in Exact Sciences in Q3 2015 and held it in 42 quarters.
- Envestnet Asset Management's Exact Sciences position peaked at $31.5M in Q2 2021.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.